SCHEMBL2168636

SCHEMBL2168636

O=C1C[C@H](O)C[C@@H](CCl)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16366005 1.00
SCHEMBL797865 1.00
SCHEMBL798189 1.00
SCHEMBL7073737 1.00
SCHEMBL15809714 1.00
SCHEMBL28742938 0.84
SCHEMBL24299777 0.81
SCHEMBL14543908 0.81
SCHEMBL13428769 0.81
SCHEMBL7654633 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1700854-B1 Intermediates for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives ASTRAZENECA UK LTD (GB) 2012-05-23 EP claimed
US-20110251406-A1 PROCESS FOR THE PREPARATION OF 2-(6-SUBSTITUTED-1,-3-DIOXANE-4-YL) ACETIC ACID DERIVATIVES ASTRAZENECA UK LTD. (GB) 2011-10-13 US claimed
EP-2788342-B1 PROCESS FOR THE PREPARATION OF A STATIN PRECURSOR DSM SINOCHEM PHARM NL BV (NL) 2018-01-24 EP disclosed
EP-2655650-B1 ENZYMATIC SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATES THEREOF LEK PHARMACEUTICALS (SI) 2017-12-20 EP disclosed
EP-2788341-B1 PROCESS FOR THE PREPARATION OF A THIOPRECURSOR FOR STATINS DSM SINOCHEM PHARM NL BV (NL) 2017-04-05 EP disclosed
EP-2665722-B1 PROCESS FOR THE PREPARATION OF DIOL SULFONES DSM SINOCHEM PHARM NL BV (NL) 2016-08-17 EP disclosed
EP-2665722-B1 PROCESS FOR THE PREPARATION OF DIOL SULFONES DSM SINOCHEM PHARM NL BV (NL) 2016-08-17 EP disclosed
US-9260423-B2 Process for the preparation of a thioprecursor for statins DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2016-02-16 US disclosed
US-9150562-B2 Process for the preparation of diol sulfones DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2015-10-06 US disclosed
US-9150562-B2 Process for the preparation of diol sulfones DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2015-10-06 US disclosed
US-9150562-B2 Process for the preparation of diol sulfones DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2015-10-06 US disclosed
WO-2007039287-A1 PROCESS FOR THE SYNTHESIS OF HMG-CoA REDUCTASE INHIBITORS LEK PHARMACEUTICALS D.D. (SI) 2007-04-12 WO disclosed
US-20060258733-A1 By reacting 2-(leaving group-methyl)-4-hydroxy-6-oxotetrahydropyran with a cyanide ion in water at a pH of 0-5; nitrile may be reduced to form an aminoethyl group; reacting with an acetal-forming agent to form a 1,3-dioxane derivative; may be further converted to atorvastatin or its calcium salt DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2006-11-16 US disclosed
EP-1317440-B1 PROCESS FOR THE PREPARATION OF 2-(6-SUBSTITUTED-1,3-DIOXANE-4-YL)ACETIC ACID DERIVATIVES ASTRAZENECA UK LTD (GB) 2006-09-27 EP disclosed
EP-1700854-A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives AstraZeneca UK Limited (GB) 2006-09-13 EP disclosed
US-20050148785-A1 Process for the preparation of 2-(6-substituted-1,-3-dioxane-4-YL) acetic acid derivatives ASTRAZENECA UK LTD. 2005-07-07 US disclosed
US-6870059-B2 Process for the preparation of 2-(6-substituted-1,-3-dioxane-4-yl)acetic acid derivatives ASTRAZENECA UK LTD. (GB) 2005-03-22 US disclosed
US-20030158426-A1 Process for the preparation of 2-(6-subtituted-1,-3-dioxane-4-yl)acetic acid derivatives ASTRAZENECA UK LTD. (GB) 2003-08-21 US disclosed
EP-1317440-A1 PROCESS FOR THE PREPARATION OF 2-(6-SUBSTITUTED-1,3-DIOXANE-4-YL)ACETIC ACID DERIVATIVES DSM N.V. (NL) 2003-06-11 EP disclosed
WO-2002006266-A1 PROCESS FOR THE PREPARATION OF 2-(6-SUBSTITUTED-1,3-DIOXANE-4-YL)ACETIC ACID DERIVATIVES DSM N.V. (NL) 2002-01-24 WO disclosed